Drugs Online |
 |
 | ||
|
Accolate Generic Zafirlukast |
|
| ||
Drugs Online » Prescription Drugs 1 » Accolate Generic Zafirlukast Product Origin: EU (Turkey) This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English. Medical Information: Accolate helps prevent asthma attacks. It is prescribed for long-term treatment. Accolate (zafirlukast) is an oral leukotriene receptor antagonist (LTRA) for the maintenance treatment of asthma. Available as a tablet it blocks the effects of substances which cause constriction of the airways build-up of mucus in the lungs and inflammation of the breathing passages. Accolate was the first LTRA to be marketed in the USA and is now approved in over 60 countries including the UK Japan Italy Spain Canada Brazil and China. Accolate is approved in the USA for adults and children aged 5 years and above. Accolate will not stop an asthma attack once it starts. You will still need to use an airway-opening medication when an attack occurs. Dosage:ADULTS The usual dose for adults and children 12 years of age and over is 20 milligrams twice a day. CHILDRENThe usual dose for children 7 to 11 years of age is 10 milligrams twice a day. Safety and effectiveness in children under 7 years of age have not been established. Buy Accolate Generic Zafirlukast and other Prescription Drugs 1 products online at Medstore. 3623
About Accolate Generic Zafirlukast: Product Type: Prescription Drugs 1 Accolate (Generic Zafirlukast ) Accolate (Generic Zafirlukast) Generic Zafirlukast 20mg 56 Tabs Generic Zafirlukast Accolate
View more Prescription Drugs 1 Drugs Online: From Gulf News: Runners should avoid prescription drugs. Statins may increase production of the enzyme creatine kinase, and hence heighten chances of muscle damage in athletes. Marathon running has increased in popularity over the past three decades, with participation in the United States rising from 25,000 runners in 1976 to nearly 470,000 in 2008. Many professional and recreational runners take prescription drugs, unaware of potential side-effects that affect runners in particular. One such class of drugs, called statins, which includes medicines such as Lipitor, Crestor and Pravachol, lowers blood cholesterol by inhibiting a cholesterol-producing enzyme and may even lower the risks of heart attack and further cardiovascular disease in a narrow category of patients. A new study forthcoming in the American Journal of Cardiology examined the effect of statins on creatine kinase (CK), an enzyme linked to muscle damage. Elevated levels of CK in the blood and muscle after exercise correlates with muscle damage. The study, conducted by Dr Beth Parker of the Henry Low Heart Centre at Connecticut's Hartford Hospital, is the first to measure CK levels in athletes taking statins after physical activity in a real-life environment rather than in a university laboratory.
| ||
